Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polymorphism of BIK as a Host Risk Factor for Severe Influenza. | DNA Cell Biol | 2025 | 40971288 | PubTator, text mining | PubMed |
| Antibacterial and anticancer activity of multifunctional iron-based magnetic nanoparticles against urinary tract infection and cystitis-related bacterial strains and bladder cancer cells. | Biomed Eng Lett | 2025 | 40917151 | PubTator, text mining | PubMed |
| Correction for Soni et al., BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza. | Proc Natl Acad Sci U S A | 2025 | 40875814 | PubTator, text mining | PubMed |
| The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy. | BMC Cancer | 2025 | 40851062 | PubTator, text mining | PubMed |
| Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation. | bioRxiv | 2025 | 40832228 | PubTator, text mining | PubMed |
| Oxidative stress and programmed cell death in diabetic wounds: A comprehensive review. | Sci Prog | 2025 | 40827034 | PubTator, text mining | PubMed |
| Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes. | Prostate | 2025 | 40825105 | PubTator, text mining | PubMed |
| Expression of regulatory and executor proteins of apoptosis in odontogenic keratocyst: a systematic review. | Med Oral Patol Oral Cir Bucal | 2025 | 40818142 | PubTator, text mining | PubMed |
| Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax. | J Transl Med | 2025 | 40814067 | PubTator, text mining | PubMed |
| BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza. | Proc Natl Acad Sci U S A | 2025 | 40627391 | PubTator, text mining | PubMed |
| KLHL5 Contributes to Colorectal Cancer Cell Survival by Promoting Cell Cycle Progression and Suppressing Apoptotic Cell Death. | Cancer Sci | 2025 | 40590665 | PubTator, text mining | PubMed |
| Exploration of the anticancer properties of Caffeic Acid in malignant mesothelioma cells. | Med Oncol | 2025 | 40493253 | PubTator, text mining | PubMed |
| Prognosis of cholangiocarcinoma patients based on multiple patterns of programmed cell death, integrated analysis of the immune microenvironment and drug sensitivity. | Front Genet | 2025 | 40438322 | PubTator, text mining | PubMed |
| SAMHD1 enhances HIV-1-induced apoptosis in monocytic cells via the mitochondrial pathway. | mBio | 2025 | 40434097 | PubTator, text mining | PubMed |
| Venetoclax used alone, or in combination with cladribine, changes the expression of apoptosis-regulating genes in chronic lymphocytic leukemia cells in vitro. | Adv Clin Exp Med | 2025 | 40432340 | PubTator, text mining | PubMed |
| Narciclasine enhances cisplatin-induced apoptotic cell death by inducing unfolded protein response-mediated regulation of NOXA and MCL1. | Cell Mol Biol Lett | 2025 | 40369444 | PubTator, text mining | PubMed |
| Harnessing the Role of ESR1 in Breast Cancer: Correlation with microRNA, lncRNA, and Methylation. | Int J Mol Sci | 2025 | 40243758 | PubTator, text mining | PubMed |
| Collaborative orchestration of BH3-only proteins governs Bak/Bax-dependent hepatocyte apoptosis under antiapoptotic protein-deficiency in mice. | Cell Death Differ | 2025 | 39994353 | PubTator, text mining | PubMed |
| Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative Approaches. | bioRxiv | 2025 | 39975128 | PubTator, text mining | PubMed |
| Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. | Nat Commun | 2025 | 39971927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=2